Antibiotic Treatment Against Methicillin-Resistant Staphylococcus aureus Hospital- and Ventilator-acquired Pneumonia: A Step Forward but the Battle Continues

Vancomycin: We Can't Get There From Here

(2011) N. Patel et al.   CLINICAL INFECTIOUS DISEASES

Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia

(2010) Nadia Z. Haque et al.   CHEST

Linezolid vs Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia

(2010) Allan J. Walkey et al.   CHEST

Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?*

(2010) Carlos M. Luna et al.   CRITICAL CARE MEDICINE

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis*

(2010) Andre C. Kalil et al.   CRITICAL CARE MEDICINE

Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit

(2010) Miguel Sánchez García   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rethinking the concepts of community-acquired and health-care-associated pneumonia

(2010) Santiago Ewig et al.   LANCET INFECTIOUS DISEASES

Effect of Linezolid Compared With Glycopeptides in Methicillin-Resistant Staphylococcus aureus Severe Pneumonia in Piglets

(2009) Carlos M. Luna et al.   CHEST

Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients

(2009) Thomas P. Lodise et al.   CLINICAL INFECTIOUS DISEASES